Gen-Probe's Q4 Revenues Slide 2 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market on Tuesday a 2 percent decline in fourth-quarter revenues as product revenues shrank 3 percent.

The company also announced a $150 million share buyback program.

For the three months ended Dec. 31, 2010, the San Diego molecular diagnostics firm posted overall revenues of $136.7 million, down from $138.9 million a year ago, and short of consensus analyst estimates of $137.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.